Skip to main content

CORRECTION article

Front. Endocrinol., 08 January 2025
Sec. Thyroid Endocrinology
Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1542771

Corrigendum: Bone metastasis in differentiated thyroid cancer: Spanish multicenter study of clinical characteristics, survival and prognostic factors

This article is a correction to:

  1. Bone metastasis in differentiated thyroid cancer: Spanish multicenter study of clinical characteristics, survival and prognostic factors

    1. Read original article
Suset Dueas-DisotuarSuset Dueñas-Disotuar1Ana Piar-Gutirrez*Ana Piñar-Gutiérrez1*Irene de Lara-RodríguezIrene de Lara-Rodríguez1Julia Sastre-MarcosJulia Sastre-Marcos2Emma Anda-ApinizEmma Anda-Apiñániz3Amelia Oleaga-AldayAmelia Oleaga-Alday4JC GalofrJC Galofré5Aida OroisAida Orois6Victoria Alczar-LzaroVictoria Alcázar-Lázaro7Laia Martínez-GuaschLaia Martínez-Guasch8Cecilia Snchez-RagnarssonCecilia Sánchez-Ragnarsson9María ngeles Glvez-MorenoMaría Ángeles Gálvez-Moreno10Cristina Familiar-CasadoCristina Familiar-Casado11Toms Martín-HernndezTomás Martín-Hernández12Ana R. Romero-LluchAna R. Romero-Lluch1 on behalf of the Thyroid Knowledge Area of the Spanish Society of Endocrinology Nutrition (TiroSEEN)
  • 1Department of Endocrinology, Hospital Universitario Virgen del Rocío, Sevilla, Spain
  • 2Department of Endocrinology, Hospital Universitario de Toledo, Toledo, Spain
  • 3Department of Endocrinology, Hospital Universitario de Navarra, Pamplona, Spain
  • 4Department of Endocrinology, Hospital Universitario de Basurto, Universidad del País Vasco (UPV/EHU), Bilbao, Spain
  • 5Department of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain
  • 6Department of Endocrinology and Nutrition, Hospital Clínic, Barcelona, Spain
  • 7Department of Endocrinology, Hospital Severo Ochoa, Leganés, Spain
  • 8Department of Endocrinology, Hospital Joan XXIII, Tarragona, Spain
  • 9Department of Endocrinology, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain
  • 10Department of Endocrinology, Hospital Universitario Reina Sofía, Córdoba, Spain
  • 11Department of Endocrinology, Hospital Clínico San Carlos, Madrid, Spain
  • 12Department of Endocrinology, Hospital Universitario Virgen Macarena, Sevilla, Spain

A Corrigendum on
Bone metastasis in differentiated thyroid cancer: Spanish multicenter study of clinical characteristics, survival and prognostic factors

By Dueñas-Disotuar S, Piñar-Gutiérrez A, de Lara-Rodríguez I, Sastre-Marcos J, Anda-Apiñániz E, Oleaga-Alday A, Galofré J, Orois A, Alcázar-Lázaro V, Martínez-Guasch L, Sánchez-Ragnarsson C, Gálvez-Moreno MÁ, Familiar-Casado C, Martín-Hernández T and Romero-Lluch AR (2024) Front. Endocrinol. 15:1466245. doi: 10.3389/fendo.2024.1466245

In the published article, two author names were incorrectly written as “Juan Carlos Galofré-Ferrater” and “Aida Orois-Añón”. The correct spelling for these author names is “JC Galofré” and “Aida Orois”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: thyroid cancer, bone metastases, survival, skeletal-related events, radioiodine, multikinase inhibitors, antiresorptive agents

Citation: Dueñas-Disotuar S, Piñar-Gutiérrez A, de Lara-Rodríguez I, Sastre-Marcos J, Anda-Apiñániz E, Oleaga-Alday A, Galofré J, Orois A, Alcázar-Lázaro V, Martínez-Guasch L, Sánchez-Ragnarsson C, Gálvez-Moreno MÁ, Familiar-Casado C, Martín-Hernández T and Romero-Lluch AR (2025) Corrigendum: Bone metastasis in differentiated thyroid cancer: Spanish multicenter study of clinical characteristics, survival and prognostic factors. Front. Endocrinol. 15:1542771. doi: 10.3389/fendo.2024.1542771

Received: 10 December 2024; Accepted: 11 December 2024;
Published: 08 January 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Dueñas-Disotuar, Piñar-Gutiérrez, de Lara-Rodríguez, Sastre-Marcos, Anda-Apiñániz, Oleaga-Alday, Galofré, Orois, Alcázar-Lázaro, Martínez-Guasch, Sánchez-Ragnarsson, Gálvez-Moreno, Familiar-Casado, Martín-Hernández and Romero-Lluch. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ana Piñar-Gutiérrez, YW5hcGluYXJnQGdtYWlsLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.